1-(Cyclopropylmethyl)-3-hydroxyquinazoline-2,4(1H,3H)-dione, 98%, 250mg

N-(4-FLUOROBENZYL)-2-OXOPYRROLIDINE-3-CARBOXAMIDE, 95.0%, 250mg

N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 98%, 250mg

5,6-Dichloro-1-ethyl-1H-benzo[d]imidazol-2(3H)-one, 95.0%, 50mg

ETHYL 3-AMINO-4-BROMOBENZOATE, 95.0%, 5g

(S)-2-((tert-butoxycarbonyl)amino)-3-(4-(pyridin-4-yl)phenyl)propanoic acid, 98%, 250mg

Methanesulfonic acid, min. 99.5%, for synthesis, 250 ml, glass packaging

4-Methyl-1,2,5-oxadiazol-3-amine, 95.0%, 2.5g

1-(prop-2-yn-1-yl)-1H-1,2,3-triazole, 95.0%, 500mg

Transition piece with olive Straight tubing olive, 14/23, 1 Piece

2-bromo-N-(4-fluorophenyl)acetamide, 95.0%, 5g

2-Chlorothiazolo[4,5-b]pyridine, 95.0%, 1g

2-Methoxy-n-(2,2,2-trifluoroethyl)aniline, 95%, 25g